Tau inhibits anterograde axonal transport and perturbs stability in growing axonal neurites in part by displacing kinesin cargo: neurofilaments attenuate tau-mediated neurite instability.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cell Motility and the Cytoskeleton

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/CM.20243PMID 18000878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Missorting of Tau in Neurons Causes Degeneration of Synapses That Can Be Rescued by the Kinase MARK2/Par-1

  2007cited by this paper
• Discoveries of Tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: A personal historical perspective

  2006cited by this paper
• Traveling the tau pathway: A personal account

  2006cited by this paper
• Tau phosphorylation and proteolysis: Insights and perspectives

  2006cited by this paper
• Solving the insoluble

  2006cited by this paper
• Tau protein, the paired helical filament and Alzheimer's disease

  2006cited by this paper
• Tau Protects Microtubules in the Axon from Severing by Katanin

  2006cited by this paper
• Molecular motors implicated in the axonal transport of tau and alpha-synuclein.

  2005cited by this paper
• Cdk5 inhibits anterograde axonal transport of neurofilaments but not that of tau by inhibition of mitogen-activated protein kinase activity.

  2005cited by this paper
• Molecular motors implicated in the axonal transport of tau and α-synuclein

  2005cited by this paper
• Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.

  2005cited by this paper
• Reexpression of vimentin in differentiated neuroblastoma cells enhances elongation of axonal neurites

  2004cited by this paper
• Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration.

  2004cited by this paper
• Mitogen-activated protein kinase regulates neurofilament axonal transport

  2004cited by this paper
• Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses.

  2003cited by this paper
• Mechanisms of Mitochondria-Neurofilament Interactions

  2003cited by this paper
• Regulation of the transition from vimentin to neurofilaments during neuronal differentiation.

  2003cited by this paper
• Microtubule Reconfiguration during Axonal Retraction Induced by Nitric Oxide

  2002cited by this paper
• Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?

  2002cited by this paper
• Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

  2002cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.

  2001cited by this paper
• Rapid intermittent movement of axonal neurofilaments observed by fluorescence photobleaching.

  2001cited by this paper
• The predominant form in which neurofilament subunits undergo axonal transport varies during axonal initiation, elongation, and maturation.

  2001cited by this paper
• Selective stabilization of microtubules within the proximal region of developing axonal neurites.

  1999cited by this paper
• Site‐Specific Dephosphorylation of Tau of Apolipoprotein E‐Deficient and Control Mice by M1 Muscarinic Agonist Treatment

  1999cited by this paper
• Kinesin-mediated transport of neurofilament protein oligomers in growing axons.

  1999cited by this paper
• Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease

  1998cited by this paper
• Acute Inactivation of Tau Has No Effect on Dynamics of Microtubules in Growing Axons of Cultured Sympathetic Neurons

  1998cited by this paper
• The tau proteins in neuronal growth and development.

  1996cited by this paper
• Tau Is Enriched on Dynamic Microtubules in the Distal Region of Growing Axons

  1996cited by this paper
• Phosphorylation of Microtubule-associated Proteins MAP2 and MAP4 by the Protein Kinase p110

  1996cited by this paper
• Role of vimentin in early stages of neuritogenesis in cultured hippocampal neurons

  1996cited by this paper
• Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells

  1995cited by this paper
• Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules.

  1995cited by this paper
• Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability.

  1994cited by this paper
• Respective roles of neurofilaments, microtubules, MAP1B, and tau in neurite outgrowth and stabilization.

  1994cited by this paper
• Transient requirement for vimentin in neuritogenesis: Intracellular delivery of anti‐vimentin antibodies and antisense oligonucleotides inhibit neurite initiation but not elongation of existing neurites in neuroblastoma

  1993cited by this paper
• Dynamics of neuronal intermediate filaments: a developmental perspective.

  1992cited by this paper
• Microtubule‐associated protein tau is required for axonal neurite elaboration by neuroblastoma cells

  1992cited by this paper
• Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons

  1990cited by this paper
• Dynamics of Phosphorylation and Assembly of the High Molecular Weight Neurofilament Subunit in NB2a/d1 Neuroblastoma

  1990cited by this paper
• The distribution of tau in the mammalian central nervous system

  1985cited by this paper
• Role of tubulin-associated proteins in microtubule nucleation and elongation.

  1977cited by this paper
• A protein factor essential for microtubule assembly.

  1975cited by this paper

• Novel strategies for targeting tau oligomers in neurodegenerative diseases

  2025cites this paper
• Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer's disease.

  2024cites this paper
• Untangling the role of tau in sex hormone responsive cancers: lessons learnt from Alzheimer's disease

  2024cites this paper
• Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights

  2023cites this paper
• The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer’s Disease

  2023cites this paper
• Mechanisms associated with the dysregulation of mitochondrial function due to lead exposure and possible implications on the development of Alzheimer’s disease

  2022cites this paper
• Numb regulates Tau levels and prevents neurodegeneration in tauopathy mouse models

  2022cites this paper
• Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways

  2022cites this paper
• Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes

  2022cites this paper
• Oxidative Stress in Tauopathies: From Cause to Therapy

  2022cites this paper
• Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer’s disease

  2022cites this paper
• Heparan Sulfate Proteoglycans in Tauopathy

  2022cites this paper
• Tau Oligomers Neurotoxicity

  2021cites this paper
• Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease

  2021cites this paper
• Numb reduces Tau levels and prevents neurodegeneration in mouse models of tauopathy in an isoform-specific manner

  2021cites this paper
• Tau in the Pathophysiology of Parkinson’s Disease

  2021cites this paper
• Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease

  2020cites this paper
• Intracerebroventricular streptozotocin induces behavioral impairments and increases short‑term C3 gene expression in the hippocampus of Wistar rats.

  2020cites this paper
• Infusion of Plasma from Exercised Mice Ameliorates Cognitive Dysfunction by Increasing Hippocampal Neuroplasticity and Mitochondrial Functions in 3xTg-AD Mice

  2020cites this paper
• Isolation and characterization of antibody fragment selective for human Alzheimer's disease brain-derived tau variants.

  2020cites this paper
• Proteotoxicity and Neurodegenerative Diseases

  2020cites this paper
• Tau interferes with axonal neurite stabilization and cytoskeletal composition independently of its ability to associate with microtubules

  2020cites this paper
• It’s all about tau

  2019cites this paper
• Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update

  2019cites this paper
• Characterization of TAG-63 and its role on axonal transport in C. elegans

  2019cites this paper
• Neurodegenerative disease mechanisms induced by tau fragmentation in a novel model of human tauopathy

  2018cites this paper
• Edinburgh Explorer Soluble forms of tau are toxic in Alzheimer's disease

  2018cites this paper
• Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane

  2018cites this paper
• Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration

  2018cites this paper
• The role of mitochondria in axon development and regeneration

  2018cites this paper
• Neuroprotective effects of cordycepin inhibit A&bgr;‐induced apoptosis in hippocampal neurons

  2018cites this paper
• Stem cell-derived mitochondria transplantation: a novel strategy and the challenges for the treatment of tissue injury

  2018cites this paper
• Primate retinal cones express phosphorylated tau associated with neuronal degeneration yet survive in old age

  2017cites this paper
• Explorer Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer ' s disease brain

  2017cites this paper
• Explorer Soluble forms of tau are toxic in Alzheimer ' s disease

  2017cites this paper
• Axonal Transport, Parkin, And Α-Synuclein; Novel Therapeutic Targets To Treat Methamphetamine Neurotoxicity

  2017cites this paper
• Assembly and turnover of neurofilaments in growing axonal neurites

  2017cites this paper
• Explorer Tau Causes Synapse Loss without Disrupting Calcium Homeostasis in the rTg 4510 Model of Tauopathy

  2017cites this paper
• Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer’s disease

  2017cites this paper
• Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer’s Disease

  2016cites this paper
• Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks.

  2016cites this paper
• Role of tau in the spatial organization of axonal microtubules: keeping parallel microtubules evenly distributed despite macromolecular crowding

  2016cites this paper
• Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.

  2016cites this paper
• Alterations in Mitochondrial Quality Control in Alzheimer’s Disease

  2016cites this paper
• Physical Exercise and Brain Mitochondrial Fitness: The Possible Role Against Alzheimer's Disease

  2016cites this paper
• Microtubule Organization and Microtubule-Associated Proteins (MAPs)

  2016cites this paper
• Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease

  2015cites this paper
• Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity

  2015cites this paper
• Activated Caspase-3 and Neurodegeneration and Synaptic Plasticity in Alzheimer's Disease

  2015cites this paper
• The Role of Telomerase Protein TERT in Alzheimer's Disease and in Tau-Related Pathology In Vitro

  2015cites this paper
• Carboxy Terminus Heat Shock Protein 70 Interacting Protein Reduces Tau-Associated Degenerative Changes

  2015cites this paper
• Mitochondria, neurosteroids and biological rhythms : implications in health and disease states

  2015cites this paper
• The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

  2014cites this paper
• Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion.

  2014cites this paper
• Tau Phosphorylation, Molecular Chaperones, and Ubiquitin E3 Ligase: Clinical Relevance in Alzheimer's Disease

  2014cites this paper
• Effect of taxoid and nontaxoid site microtubule‐stabilizing agents on axonal transport of mitochondria in untransfected and ECFP‐htau40‐transfected rat cortical neurons in culture

  2014influential citation
• Divergent and convergent roles for kinases and phosphatases in neurofilament dynamics

  2014cites this paper
• AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons.

  2014cites this paper
• March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease.

  2014cites this paper
• Protein phosphorylation in neurodegeneration: friend or foe?

  2014cites this paper
• Synaptic alterations in the rTg4510 mouse model of tauopathy

  2013cites this paper
• Ecstasy¿s Neurotoxicity: In Vitro Findings from Mitochondria to the Cell

  2013cites this paper
• ANÁLISE DA MOBILIDADE MITOCONDRIAL EM CÉLULAS VIVAS DO HIPOCAMPO, SUBSTÂNCIA NEGRA E LOCUS COERULEUS ANTERIOR À AGREGAÇÃO PROTEICA ENVOLVIDA EM NEURODEGENERAÇÃO.

  2013cites this paper
• Tau Causes Synapse Loss without Disrupting Calcium Homeostasis in the rTg4510 Model of Tauopathy

  2013cites this paper
• Analysis of Reelin function in the molecular mechanisms underlying Alzheimer’s disease

  2013cites this paper
• Conséquences de l'invalidation génétique et pharmacologique des récepteurs adénosinergiques A2A dans un modèle de pathologie Tau. Relation avec les aspects neuro-inflammatoires

  2013cites this paper
• MAPping out distribution routes for kinesin couriers

  2013cites this paper
• he intersection of amyloid beta and tau in glutamatergic synaptic ysfunction and collapse in Alzheimer ’ s disease

  2013cites this paper
• The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.

  2013cites this paper
• Abnormal interaction of VDAC 1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer ’ s disease

  2012cites this paper
• Loss of Axonal Mitochondria Promotes Tau-Mediated Neurodegeneration and Alzheimer's Disease–Related Tau Phosphorylation Via PAR-1

  2012cites this paper
• Etudes biologiques de nouveaux radiotraceurs pour l'imagerie moléculaire de la maladie d'Alzheimer

  2012cites this paper
• Tau and tauopathies.

  2012cites this paper
• Soluble forms of tau are toxic in Alzheimer’s disease

  2012cites this paper
• Drugs for Alzheimer's

  2012cites this paper
• Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.

  2012cites this paper
• Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration

  2012cites this paper
• Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy

  2012cites this paper
• Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.

  2012cites this paper
• New Small Molecule Drug Discovery for Alzheimer's Disease

  2012cites this paper
• Regulation of Mitochondrial Transport and Inter-Microtubule Spacing by Tau Phosphorylation at the Sites Hyperphosphorylated in Alzheimer's Disease

  2012cites this paper
• Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.

  2011cites this paper
• Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.

  2011cites this paper
• Rehabilitating a brain with Alzheimer’s: a proposal

  2011cites this paper
• Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability.

  2011cites this paper
• Yeast as a Model System to Study Tau Biology

  2011cites this paper
• Tau/PTL-1 associates with kinesin-3 KIF1A/UNC-104 and affects the motor's motility characteristics in C. elegans neurons.

  2011cites this paper
• hnRNP K post-transcriptionally co-regulates multiple cytoskeletal genes needed for axonogenesis

  2011cites this paper
• The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics

  2011cites this paper
• Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.

  2011cites this paper
• Etude du mécanisme d’agrégation de la protéine Tau et son inhibition par des composés polyphénoliques

  2011cites this paper
• Probable Participation of 14-3-3 in Tau Protein Oligomerization and Aggregation

  2011cites this paper
• Modulation of growth factor-induced ERK signaling by the microtubule associated protein tau

  2010cites this paper
• Tau oligomers and aggregation in Alzheimer’s disease

  2010cites this paper
• Tau Potentiates Nerve Growth Factor-induced Mitogen-activated Protein Kinase Signaling and Neurite Initiation without a Requirement for Microtubule Binding*

  2010cites this paper
• Organizational dynamics, functions, and pathobiological dysfunctions of neurofilaments.

  2009cites this paper
• The role of tau in neurodegeneration

  2009cites this paper
• Calcium-sensing receptor (CaSR) in human brain's pathophysiology: roles in late-onset Alzheimer's disease (LOAD).

  2009cites this paper
• Complexity of mitochondrial dynamics in neurons and its control by ADP produced during synaptic activity.

  2009cites this paper
• Exonic Point Mutations of Human Tau Enhance its Toxicity and Cause Characteristic Changes in Neuronal Morphology, Tau Distribution and Tau Phosphorylation in the Lamprey Cellular Model of Tauopathy

  2009cites this paper